Lawyers Provide Free Valsartan Recall Case Evaluations Nationwide
Amid concern that certain generic valsartan and valsartan HCTZ pills may have been distributed for years with impurities that increase the risk of cancer, the drug recall lawyers at Saiontz & Kirk, P.A. are reviewing cases for users of the hypertension drug who have been diagnosed with:
- Liver Cancer
- Kidney Cancer
- Lung Cancer
- Liver Injury Resulting in Hospitalization
All valsartan recall lawsuits are being evaluated by our law firm on a contingency fee basis, which means that there are never any out-of-pocket expenses to hire a lawyer and we receive no fees or expenses unless a recovery is obtained. Request a free consultation and claim evaluation.
Valsartan and Valsartan HCTZ Recall
Contact Our Lawyers To Review a VALSARTAN RECALL CASE
In July 2018, the FDA announced the recall for several types of generic valsartan, indicating that the manufacturing process has resulted in impurities, including a substances known as N-nitrosodimethylamine (NDMA), which is a known to increase the risk of cancer.
The contaminated ingredients may have been contained in certain version of valsartan and valsartan HCTZ for years, exposing users to a risk of liver cancer, kidney cancer and other serious side effects.
NDMA is identified as a cancer-causing agent by the U.S. Environmental Protection Agency (EPA) and other government agencies worldwide, indicating that the safe limit for human ingestion is 96 nanograms. However, investigations suggest recalled valsartan pills exceeded those levels.
A number of valsartan recalls have been announced by the FDA, impacting batches sold by a number of pharmaceutical companies or repackagers, including:
- Major Pharmaceuticals
- Teva Pharmaceuticals
- Solco Healthcare
- A-S Medication Solutions LLC
- Bryant Ranch Prepack Inc.
- H.J. Harkins Company, Inc.
- Lake Erie Medical, doing business as Quality Care Products LLC
- NuCare Pharmaceuticals
- Proficient Rx
According to investigators, it appears that the NDMA is a byproduct and impurity resulting from the manufacturing process. Some companies may have been distributing the contaminated valsartan pills for four years and the investigation of what drugs may be impacted is continuing.
Valsartan Class Action Lawyers
Individual cancer lawsuits and potential valsartan class action lawsuits are being evaluated for individuals who have been exposed to NDMA in the hypertension drug.
It appears that the manufacturers of generic valsartan failed to conduct adequate testing to ensure that the drugs were safe for consumers, potentially exposing them to a cancer-causing agent since 2012.
If you, a friend or family member has been diagnosed with cancer or experienced problems after taking recalled valsartan, request a free consultation and claim evaluation.